Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 21.32 K6.56 M8.48 M5.41 M 20.46 M Research & development ———— — Operating income -21.32 K-4.18 M-424 K-2.64 M -7.27 M Non-Operating Income, Total 40 K926 K850 K806 K 2.62 M Interest expense, net of interest capitalized ———100 K — Non-Operating Income, excl. Interest Expenses 40 K925 K850 K702 K 2.52 M Unusual income/expense 01 00004 000 5 000 Pretax income -21.32 K-3.25 M426 K-1.83 M -4.68 M Equity in earnings ———— — Taxes ——346 K0 — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -21.32 K-3.25 M413 K-1.83 M -4.7 M Discontinued operations ———— — Net income -21.32 K-3.25 M413 K-1.83 M -4.7 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -21.32 K-3.25 M-1 000-1.83 M -5.11 M Basic earnings per share (Basic EPS) -21.32-0.12-0.08-0.06 -21.58 Diluted earnings per share (Diluted EPS) -21.32-0.12-0.08-0.06 -21.58 Average basic shares outstanding 1 00027.81 M19.53 M29.65 M — Diluted shares outstanding 1 00027.81 M19.53 M29.65 M — EBITDA 21.02 M-4.04 M-566 K-2.57 M 13.85 M EBIT 21.21 M-4.18 M-756 K-2.64 M 13.63 M Cost of revenue —19.89 M24.91 M23.16 M — Other cost of goods sold ———— — Depreciation & amortization (cash flow) -184 K138 K190 K75 K 219 K